NO152508C - Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperazinoquinazolinderivat - Google Patents

Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperazinoquinazolinderivat

Info

Publication number
NO152508C
NO152508C NO801196A NO801196A NO152508C NO 152508 C NO152508 C NO 152508C NO 801196 A NO801196 A NO 801196A NO 801196 A NO801196 A NO 801196A NO 152508 C NO152508 C NO 152508C
Authority
NO
Norway
Prior art keywords
piperazinoquinazoline
derivative
preparation
new therapeutic
therapeutic active
Prior art date
Application number
NO801196A
Other languages
English (en)
Norwegian (no)
Other versions
NO152508B (no
NO801196L (no
Inventor
Simon Fraser Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10504770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO152508(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NO801196L publication Critical patent/NO801196L/no
Publication of NO152508B publication Critical patent/NO152508B/no
Publication of NO152508C publication Critical patent/NO152508C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO801196A 1979-04-25 1980-04-24 Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperazinoquinazolinderivat NO152508C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914431 1979-04-25

Publications (3)

Publication Number Publication Date
NO801196L NO801196L (no) 1980-10-27
NO152508B NO152508B (no) 1985-07-01
NO152508C true NO152508C (no) 1985-10-09

Family

ID=10504770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801196A NO152508C (no) 1979-04-25 1980-04-24 Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperazinoquinazolinderivat

Country Status (33)

Country Link
US (1) US4279910A (ko)
JP (1) JPS55145684A (ko)
KR (1) KR830002567B1 (ko)
AR (1) AR224400A1 (ko)
AT (1) AT373596B (ko)
BE (1) BE882967A (ko)
CA (1) CA1132558A (ko)
CH (1) CH642076A5 (ko)
CS (1) CS209950B2 (ko)
DD (1) DD150202A5 (ko)
DE (1) DE3015676A1 (ko)
DK (1) DK121080A (ko)
EG (1) EG14651A (ko)
ES (1) ES8101588A1 (ko)
FI (1) FI64592C (ko)
FR (1) FR2455042A1 (ko)
GB (1) GB2049683B (ko)
GR (1) GR68049B (ko)
HU (1) HU184747B (ko)
IE (1) IE49705B1 (ko)
IL (1) IL59900A (ko)
IT (1) IT1141490B (ko)
LU (1) LU82394A1 (ko)
NL (1) NL182563C (ko)
NO (1) NO152508C (ko)
NZ (1) NZ193511A (ko)
PH (1) PH15156A (ko)
PL (1) PL121470B1 (ko)
PT (1) PT71139A (ko)
SE (1) SE435061B (ko)
SU (1) SU915804A3 (ko)
YU (1) YU41709B (ko)
ZA (1) ZA802488B (ko)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
GB2049683A (en) 1980-12-31
CH642076A5 (de) 1984-03-30
ATA218980A (de) 1983-06-15
CS209950B2 (en) 1981-12-31
YU41709B (en) 1987-12-31
IE800827L (en) 1980-10-25
FR2455042A1 (fr) 1980-11-21
AT373596B (de) 1984-02-10
DK121080A (da) 1980-10-26
NO152508B (no) 1985-07-01
KR830002567B1 (ko) 1983-11-14
NO801196L (no) 1980-10-27
JPS55145684A (en) 1980-11-13
YU113180A (en) 1983-02-28
FI64592B (fi) 1983-08-31
IE49705B1 (en) 1985-11-27
NL182563B (nl) 1987-11-02
PT71139A (en) 1980-05-01
GR68049B (ko) 1981-10-29
PL121470B1 (en) 1982-05-31
IL59900A (en) 1983-11-30
SU915804A3 (en) 1982-03-23
FI801306A (fi) 1980-10-26
FR2455042B1 (ko) 1983-05-20
NZ193511A (en) 1982-03-30
NL182563C (nl) 1988-04-05
AR224400A1 (es) 1981-11-30
FI64592C (fi) 1983-12-12
IL59900A0 (en) 1980-06-30
SE435061B (sv) 1984-09-03
IT1141490B (it) 1986-10-01
JPS5738591B2 (ko) 1982-08-16
CA1132558A (en) 1982-09-28
LU82394A1 (fr) 1980-07-31
PL223755A1 (ko) 1981-02-13
NL8002387A (nl) 1980-10-28
DE3015676A1 (de) 1980-11-13
HU184747B (en) 1984-10-29
ES490867A0 (es) 1980-12-16
GB2049683B (en) 1983-01-26
PH15156A (en) 1982-08-24
DD150202A5 (de) 1981-08-19
ES8101588A1 (es) 1980-12-16
ZA802488B (en) 1981-08-26
US4279910A (en) 1981-07-21
EG14651A (en) 1985-03-31
IT8021598A0 (it) 1980-04-23
SE8003122L (sv) 1980-10-26
KR830002758A (ko) 1983-06-30
BE882967A (fr) 1980-10-24

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO150800C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO151702C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte acetofenoner
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO150916C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO150762C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-aza-2-(2,2,2)-bicyklo-oktan
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO146057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater